Michael Dixon, president and CEO of UNeMed and Bio Nebraska board member, talked to Omaha Magazine about working with inventors at the University of Nebraska Medical Center, the University of Nebraska at Omaha, and Nebraska Medicine to help guide the process from idea to commercialization.
In 2021 alone, UNeMed reported 117 active licenses, 40 products on the market, and 161 total patent applications. It was also credited with spawning seven new startups. The organization’s efforts generated $2.15 million in revenue, as well as $1.46 million in sponsored research. Its 102 U.S. patent applications and 26 U.S. patents awarded that year were both records for the organization.By Dwain Hebda, Omaha Magazine